(NYSE: SOLV) Solventum's forecast annual revenue growth rate of 1.14% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.89%.
Solventum's revenue in 2025 is $8,308,000,000.On average, 4 Wall Street analysts forecast SOLV's revenue for 2025 to be $1,467,880,039,117, with the lowest SOLV revenue forecast at $1,456,163,258,013, and the highest SOLV revenue forecast at $1,472,580,627,195. On average, 4 Wall Street analysts forecast SOLV's revenue for 2026 to be $1,462,685,672,159, with the lowest SOLV revenue forecast at $1,354,984,782,189, and the highest SOLV revenue forecast at $1,516,804,287,174.
In 2027, SOLV is forecast to generate $1,495,079,054,558 in revenue, with the lowest revenue forecast at $1,404,223,048,699 and the highest revenue forecast at $1,557,116,298,000.